BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29538252)

  • 1. Racial Differences in Survival From Epithelial Ovarian Cancer Are Associated With Stage at Diagnosis and Use of Neoadjuvant Therapy: A 10-Year Single-Institution Experience With a Racially Diverse Urban Population.
    Miller EM; Tymon-Rosario J; Strickler HD; Xie X; Xue X; Kuo DYS; Makhija SK; Nevadunsky NS
    Int J Gynecol Cancer; 2018 May; 28(4):749-756. PubMed ID: 29538252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
    Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
    Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.
    Washington CJ; Karanth SD; Wheeler M; Aduse-Poku L; Braithwaite D; Akinyemiju TF
    Cancer Causes Control; 2024 Mar; 35(3):487-496. PubMed ID: 37874478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unplanned hospitalizations in a racially and ethnically diverse population of women receiving chemotherapy for epithelial ovarian cancer.
    Dioun S; Jorgensen JR; Miller EM; Tymon-Rosario J; Xie X; Xue X; Kuo DY; Nevadunsky NS
    Gynecol Oncol; 2018 Oct; 151(1):134-140. PubMed ID: 30149897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001-2015.
    Westrick A; Schlumbrecht M; Hlaing WM; Kobetz EK; Feaster D; Balise R
    Cancer Causes Control; 2020 Apr; 31(4):333-340. PubMed ID: 32052218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
    Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
    Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in treatment and survival among elderly ovarian cancer patients.
    Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
    Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.
    Beckmeyer-Borowko AB; Peterson CE; Brewer KC; Otoo MA; Davis FG; Hoskins KF; Joslin CE
    Cancer Causes Control; 2016 Oct; 27(10):1261-71. PubMed ID: 27590306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
    Liu YL; Zhou QC; Iasonos A; Filippova OT; Chi DS; Zivanovic O; Sonoda Y; Gardner G; Broach V; OCearbhaill R; Konner JA; Aghajanian CA; Long K; Tew W
    Int J Gynecol Cancer; 2020 Oct; 30(10):1554-1561. PubMed ID: 32522770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in ovarian cancer treatment and overall survival according to race: An update.
    Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
    Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of intraperitoneal chemotherapy for optimally cytoreduced advanced stage epithelial ovarian cancer: A 10-year single institution experience with a racially diverse urban population.
    Miller EM; Tymon-Rosario J; Xie X; Xue X; Gressel GM; Miller DT; Kuo DY; Nevadunsky NS
    Gynecol Oncol; 2017 Oct; 147(1):36-40. PubMed ID: 28751119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in treatment and survival from ovarian cancer.
    Hildebrand JS; Wallace K; Graybill WS; Kelemen LE
    Cancer Epidemiol; 2019 Feb; 58():77-82. PubMed ID: 30528360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
    Sakhuja S; Yun H; Pisu M; Akinyemiju T
    J Ovarian Res; 2017 Aug; 10(1):57. PubMed ID: 28830564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center.
    Bristow RE; Ueda S; Gerardi MA; Ajiboye OB; Ibeanu OA
    Gynecol Oncol; 2011 Aug; 122(2):319-23. PubMed ID: 21632099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer.
    Chambers LM; Kuznicki M; Yao M; Chichura A; Gruner M; Reizes O; Debernardo R; Rose PG; Michener C; Vargas R
    Gynecol Oncol; 2020 Dec; 159(3):699-705. PubMed ID: 32950250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.